Beste Aplastische Anämie Hämatologe-Onkologen - TOP-68 Ärzte

• Dr. Zafer Gulbas ist auf die Behandlung der aplastischen Anämie spezialisiert.
• Verwendet Knochenmarktransplantation, immunsuppressive Therapie und Bluttransfusionen bei aplastischer Anämie.
• Internationale Erfahrung in den USA, Kanada und Israel.
• Gründer des Bone Marrow Transplantation Center am Anadolu Medical Center.
• Verfügt über medizinische Onkologie- und Hämatologie-Expertise von renommierten Institutionen.
• Beteiligt sich an Online-Konsultationen für Patienten mit aplastischer Anämie.
• Fließend Englisch und Türkisch, um einem breiteren Patientenkreis gerecht zu werden.

Professor Fabio Ciceri ist Leiter der Abteilung für Hämatologie und Knochenmarktransplantation am San Raffaele Research Hospital und des Bluttransfusionszentrums. Er hat über 180 Artikel veröffentlicht und bekleidet seit 1989 verschiedene medizinische und lehrende Positionen. Er ist Mitglied mehrerer Organisationen im Zusammenhang mit Hämatologie und wurde mit einem Merit Recognition Award der Universität Ferrara ausgezeichnet. Er ist leitender Prüfarzt in klinischen Studien zur Zell- und Gentherapie für hämatologische Krebserkrankungen, Immunschwächen und neuromuskuläre Erkrankungen.

• Spezialisiert auf die Behandlung aplastischer Anämie mit über 20 Jahren Erfahrung.
• Verwendet Knochenmarktransplantation, immunsuppressive Therapie und Bluttransfusionen.
• Die internationale Praxis umfasst die Türkei, das NATO-KFOR-Kommando und die türkisch-zyprischen Friedenstruppen.
• Über 40 Veröffentlichungen zur Krebsforschung, die zum Wissen über aplastische Anämie beitragen.
• Akkreditiert als medizinischer Onkologe und Facharzt für Innere Medizin.
• Mitglied der Türkischen Vereinigung für medizinische Onkologie.
• Berät Patienten online, auch solche mit aplastischer Anämie.
• Spricht Türkisch und Englisch und unterstützt so die Kommunikation mit unterschiedlichen Patienten.

Dr. KK Iswaran ist ein sehr erfahrener Geburtshelfer und Gynäkologe mit mehr als 25 Jahren Erfahrung in den Bereichen Geburtshilfe und Gynäkologie, Reproduktionsmedizin, IUI – intrauterine Insemination, Verfahren zur Ovulationsinduktion, Eierstockbohrung (Multiperforation), Harnröhrenklappen und mehr. Er hat ein Stipendium, Diplom und MBBS des Ronald O Perelman and Claudia Cohen Centre, Irland, bzw. der University of Mysore, Indien.

Dr. Ronit El Hasid ist Leiterin der Pädiatrischen Onkohämatologie und Onkologie am Dana Dwek Kinderkrankenhaus (Sourasky). Sie ist spezialisiert auf Knochenmark- und Nabelbluttransplantationen und hat über 300 Transplantationen durchgeführt und 50 Artikel und 40 Berichte veröffentlicht. Sie ist Mitglied der American Association for Hematology und der Israeli Society for Pediatric Hematooncology und hat zuvor im City of Hope Hospital (Los Angeles) und anderen medizinischen Zentren in Israel praktiziert.

• Spezialisiert auf die Behandlung von aplastischer Anämie mit mehr als 35 Jahren Erfahrung.
• Zu den Behandlungsmethoden gehören Knochenmarktransplantation, immunsuppressive Therapie und Bluttransfusionen.
• Zur internationalen Praxis gehört Deutschland, das für seine fortschrittliche medizinische Forschung bekannt ist.
• Von der Zeitschrift Focus als einer der besten Onkologen Deutschlands ausgezeichnet.
• Verfügt über Zertifizierungen in Onkologie und Hämatologie und gewährleistet so eine spezialisierte Versorgung.
• Mitglied von Berufsverbänden, die ihr Fachwissen durch Zusammenarbeit erweitern.
• Bietet Fernkonsultationen an und ist so für internationale Patienten zugänglich.
• Spricht fließend Deutsch und Englisch und bedient eine breitere Patientengruppe.

Areas of Interest

1. Bone marrow transplantation
2. Leukemia
3. Lymphoma
4. Multiple myeloma
5. Thalassemia
6. Bone marrow diseases
7. Plasmapheresis

Education
2005 Graduated from Hacettepe University, Faculty of Medicine
2010 Hacettepe University, Faculty of Medicine Internal Medicine Specialist
2014 Ankara University, Faculty of Medicine Hematology Specialist

Experience
October 2010 - December 2010 Internal Medicine Specialist at Ankara Oncology Hospital
December 2010 - April 2011 Hematology Sub-branch Assistant at Ankara Oncology Hospital
September 2014 - May 2016 Hematology Specialist at Kütahya Dumlupınar University Evliya Çelebi Training and Research Hospital
May 2016 - March 2018 Ufuk University, Faculty of Medicine, Hematology Department Faculty Member
March 2018 - October 2018 Hitit University, Faculty of Medicine, Hematology Department Faculty Member
November 2018 - January 2019 Medical Park Bahçelievler Hematology and Bone Marrow Transplantation Unit physician
February 2019 - June 2022 Present Bayındır Söğütözü Hospital Hematology and Stem Cell Transplantation Unit, Assistant Physician in Charge
June 2022 - July 2022 Afyonkarahisar Health Sciences University, Head of Hematology Department

Qualification Certificates
Internal Medicine Board Qualification Certificate, 2009
Hematology Board Qualification Certificate, 2014
English Proficiency 2017/7 e-YDS Score: 71.25
Internal Medicine Specialization Thesis Addition of 9-Week Trastuzumab to Adjuvant Treatment in Both Positive Breast Cancer Patients Retrospective Analysis

Education Abroad
Between October and December 2007 (3 months) Intensive Care Education at University of Florida, United States
Between December 2013 and January 2014 (2 months) Flow Cytometry Education at Salamanca University, Spain

Courses, Awards, and Certificates
1 Year of Work Certificate in Bone Marrow Transplantation, 2017
Blood Banking and Transfusion Medicine Certificate 2017
“Physician of the Year” Award in Kütahya, 2014
Laboratory GMP, GLP, ISO /IEC 17025: 2012 Certificates, 2014
Good Clinical Practices Certificate, 2013
Şeref Zileli Successful Assistant of the Year Award, 2009
RIA Certificate, 2005

Research and Publications

Patent
1. Half antibody with the fc portion removed (fab) for medical use. Inventor: Mehmet Özen. No:2016/0910. Patent under review.

Scientific Studies
A. Publications in International Journals under SCI Expanded


 Turkish book section

1. Ozen M, Konuk N. Immune thrombocytopenic purpura. Turkoz Sucak G, editor. Current Topics in Immunohematology. 1st Edition. Ankara: Turkey Clinics; 2021. p.8-12.

2. Özen M, Ural AU. Hematological diseases and mesenchymal stem cell applications. Türköz Sucak G, editor. Current Topics in Immunohematology. 1st Edition. Ankara: Turkey Clinics; 2021. p.91-4.

3. Ozen M. Hematopoiesis and Hematopoietic Growth Factors. MediHealth & Hippocrates INTERNAL DISEASES with Current Guidelines 2022. p1607-10

Eduardo Fernandez, MD

Medical Doctor & Stem Cell Expert

Dr. Eduardo Fernandez is a distinguished medical professional specializing in stem cell therapies and regenerative medicine. He is a certified member of the Mexican College of Stem Cells and Regenerative Medicine, as well as the Mexican Council of Stem Cells for Therapeutic and Research Purposes. Dr. Fernandez’s certifications are the result of a rigorous 8-hour examination process, reserved for a select group of doctors who possess advanced knowledge and experience in these cutting-edge treatments. With only 50 certified doctors in Mexico, Dr. Fernandez’s expertise is highly sought after and respected.

In addition to his national recognition, Dr. Fernandez is awaiting international certification from the renowned International Society for Stem Cell Research (ISSCR). Membership in this prestigious organization signifies Dr. Fernandez’s extensive experience and expertise in stem cell treatments. The ISSCR includes prominent scientists from renowned universities such as Harvard, Yale, Stanford, and other esteemed institutions worldwide. Being a part of this elite society represents the pinnacle of honor and prestige in the field of stem cell therapies.

Furthermore, Dr. Fernandez is also seeking membership and international certification from the International Society for Extracellular Vesicles (ISEV), the largest community of extracellular vesicle researchers globally. With only two thousand members worldwide, ISEV’s select nature underscores Dr. Fernandez’s exceptional dedication to advancing scientific knowledge in the study of exosomes and cellular messengers. By pursuing membership in ISEV, Dr. Fernandez continues to demonstrate his commitment to staying at the forefront of research and innovation in the field of regenerative medicine.

• Dr. Eckhart Weidemann zeichnet sich durch die Behandlung aplastischer Anämie aus.
• Verwendet Knochenmarktransplantation, immunsuppressive Therapie und Bluttransfusionen.
• International ausgebildet, mit umfangreicher Praxis in Deutschland.
• Leiter der Hämatologie an der Nordwest-Klinik, bekannt für Bluterkrankungen.
• Verfügt über mehr als drei Jahrzehnte Erfahrung in der Hämatologie.
• Bietet Online-Konsultationen für weltweite Patientenzugänglichkeit.
• Fließende Deutsch- und Englischkenntnisse sorgen für eine klare Kommunikation.

• Experte für die Behandlung aplastischer Anämie mit Spezialisierung auf Knochenmarktransplantation.
• Verwendet immunsuppressive Therapie, Wachstumsfaktoren und Stammzelltransplantation zur Behandlung.
• Die internationale Praxis umfasst Spanien und bietet globales Fachwissen in der Behandlung von aplastischer Anämie.
• Dr. Susana Rives Sola ist für pädiatrische Hämatologie und Onkologie akkreditiert.
• Mitglied renommierter medizinischer Fachgesellschaften, die das Wissen über hämatologische Erkrankungen erweitern.
• Berät Patienten mit aplastischer Anämie online und bietet zugängliche Pflegeoptionen.
• Fließende Spanisch- und Englischkenntnisse sorgen für eine klare Kommunikation mit unterschiedlichen Patienten.

Medical Experience:

- 2024 - Present: Memorial Şişli Hospital  

 Specialist in Internal Medicine and Hematology / Istanbul

- 2017 - 2024: Istanbul Florence Nightingale Hospital  

 Specialist in Internal Medicine and Hematology / Istanbul

- 2015 - 2017: Eskişehir Yunus Emre State Hospital  

 Hematology Specialist - Compulsory Service / Eskişehir

Medical Education:

- 2020 - 2024: Istanbul Florence Nightingale Hospital  

 Demiroğlu Bilim University, Faculty of Medicine / Istanbul, Turkey

- 2017 - 2020: Istanbul Florence Nightingale Hospital  

 Demiroğlu Bilim University, Faculty of Medicine / Istanbul, Turkey

- 2011 - 2015: Eskişehir Osmangazi University, Faculty of Medicine, Department of Hematology / Eskişehir, Turkey

- 2009 - 2011: Harvard University, Faculty of Medicine / Boston, USA

- 2000 - 2008: Ankara University, Faculty of Medicine / Ankara, Turkey

- 1994 - 2000: Ankara University, Faculty of Medicine / Ankara, Turkey

Attended Professional Trainings, Courses, and Conferences:

- European Society for Blood and Marrow Transplantation, 3rd EBMT International Transplant Course, Barcelona, Course, 07.09.2018-09.09.2018 (International)

- Turkish Academy of Blood Science, Lymphoma Masterclass, Istanbul, Course, 01.09.2016-01.03.2017 (National)

- Advanced Life Support Course, Istanbul

Membership in Professional Associations:

- European Society for Blood and Marrow Transplantation

- Turkish Academy of Blood Science

- Advanced Life Support Course

Education

• Ege Faculty of Medicine 1978
• Specialization in Pediatrics 1982
• Subspecialty Pediatric Oncology 2002 (EU Faculty of Medicine)
• Pediatric Hematology and Oncology 2012 (EU Faculty of Medicine)
• Deputy Chief of Clinic 1988 Tepecik EAH
• Clinical Chief 1993 Tepecik EAH
• Associate Professorship 1995
• Professorship  2002
• Ege U. Faculty of Medicine, faculty member 1998 – 2022
• EU Faculty of Medicine Department of Pediatrics 2009-2018
• Member of Tepecik Education Planning and Coordination Board (1993-1998)
• SSI Tepecik Hospital Ethics Committee Chairman (1996-1998)
• Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group Co-Chair" (2002-2006)
• Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group" (2006-2008)
• Turkish Society of Pediatric Hematology - Responsible for Bone Marrow Transplantation "Online" Data Registry System 2007-ongoing.
• Ege University Regenerative Medicine and Stem Cell Commission Chairman, 2011-2021

Institutional Memberships

• Turkish Medical Association İzmir and Kocaeli Branch
• Turkish National Pediatric Association - İzmir
• European Group for Bone Marrow Transplantation (EBMT); Ege University Pediatric Bone Marrow Transplantation Unit was accredited by the European Group for Bone Marrow Transplantation (EBMT) in June 2007.
• Turkish Society of Pediatric Hematology - Board Member for two terms (2005-2009)
• Turkish Society of Hematology - Board Member for two terms (2001/2005)
• Turkish Pediatric Oncology Association
• Bone Marrow Transplantation Foundation (KITVAK) Member of the Board of Trustees

Units he is the founder of                        

1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990) 
2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992) 
3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998) 
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.  

Transplantation units that he contributed to the establishment of                        

1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019) 
2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020) 
3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)

Awards

• Thrombotic parameters in bone marrow stem cell transplant patients, Pediatric Hematology Congress, Trabzon 2003
• CD133 Antigen in Stem Cell: Pediatric Hematology Congress 2005. Research award
• The role of Toll like receptors in febrile neutropenic patients, Best poster award. Turkish Hematology Congress 2008, Çeşme-İzmir
• National pediatric stem cell transplantation activity- Oral presentation second prize, Turkish Hematology Society Stem Cell Transplantation Congress, 2022, Antalya

Publications

Kansoy S. "Bone Marrow and Stem Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir

Kansoy S. Bone marrow transplantation in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir

Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5

Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003

Kansoy S. Stem Cell Applications in Bone Marrow and Stem Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005

Kansoy S. Cord Blood as a Stem Cell Source. Stem Cell Special Issue. Turkey Clinics, 2008

Kansoy S. Stem Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017

Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017

Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999.  (1.05 points)

Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)

Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003. 

Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016

Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017

Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020

National pediatric stem cell transplant activity, 2020

Childhood stem cell transplantation indications, Turkey Clinics - International book 2020

In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.

Assoc. Prof. Dr. Oğuzhan BABACAN completed his undergraduate, specialty and sub-specialty education at GATA Military Medical Faculty/Ankara. After becoming a specialist in Pediatrics, he worked in the field of Social Pediatrics for two years, where Healthy Baby Monitoring and vaccine follow-up were carried out. Then, she completed her subspecialty training in Pediatric Hematology and Oncology and continued her studies in the field of pediatric blood and cancer diseases. In addition to the treatment of children suffering from leukemia, lymphoma, solid tumors and other blood diseases, she has been working in the Bone Marrow Transplantation (Transplant) Unit for 13 years in Allogeneic (unrelated and intrafamilial), Autologous (from the patient himself) and Haploidentical (partially HLA compatible) hematopoietic stem cell transplantation. In 2018, he received the title of Associate Professor in the field of Pediatric Hematology and Oncology Science/Art.

MEDICAL AREAS OF INTEREST

Healthy baby follow-up and vaccinations

Lymph node enlargement

Pediatric patients with anemia (anemia)

Leukemia

Lymphoma

Bone Marrow Transplant

ITP

Thalassemias

Hemophiliacs

Solid tumors

Hemangioma

Childhood blood disorders

Children with frequent infections

Fever of unknown origin

Malnutrition in children

Dr. Toluy Özgümüş has graduated from Istanbul University, Cerrahpaşa Faculty of Medicine in 2008 and completed his internal medicine specialty training at Haydarpaşa Numune Training and Research Hospital between 2009 and 2013. He received his Hematology subspecialty training at Marmara University Hematology Department between 2014-2017; He performed his compulsory service at Kars Harakani State Hospital between 2017-2019. He worked at Sancaktepe Şehit Prof. Dr. Ilhan Varak Training and Research Hospital between 2019-2023.

He is experienced in the field of bleeding and coagulation disorders, especially coagulation disorders (thrombophilia), and has dealt with the diagnosis and treatment of more than 1000 patients. Since he worked in the pandemic hospital of the Anatolian side of Istanbul during the pandemic period, he has extensive experience in the hematological findings of Covid-19 infection and the management of Covid-19 infection in hematological diseases. Hundreds of patient experiences are available in the diagnosis of myeloproliferative diseases such as Polycythemia Vera and Essential Thrombocytosis, in their differentiation from blood cell elevations due to other frequently confused causes, and in their treatment. He has experience in the diagnosis and all treatment processes of rare hematological cancers such as multiple myeloma, acute and chronic leukemias, lymphomas and histiocytosis, as well as bone marrow transplantation.

MEDICAL INTERESTS 

Clotting Disorders (Thrombophilia)

Bleeding Disorders

Myeloproliferative Diseases

Anemias (Anemia)

Acute and Chronic Leukemias

lymphomas

Bone marrow transplantation

Assoc. Prof. Ali Eser received his medical education at Uludağ University Faculty of Medicine; He completed his internal medicine residency training at Istanbul Training and Research Hospital and his hematology residency training at Marmara University.

Afterward, he completed his compulsory service at Marmara University Hematology Clinic, firstly at Çanakkale University and then at Bezmialem Vakıf University. He served as a lecturer. After working as a hematology specialist and assistant physician in charge of the adult bone marrow transplant unit for 2 years at Hisar Intercontinental Hospital, he worked as a lecturer at Bezmialem Vakıf University and in the adult bone marrow transplant unit at Istanbul Yeniyüzyıl University, and finally for 1 year. He worked as the responsible physician of the adult bone marrow transplant unit at Liv Hospital Gaziantep Hospital for some time. He received the title of associate professor in March 2022.

Univ.-Prof. Dr. Wolfgang Johannes Köstler ist Facharzt für Innere Medizin, Hämatologie/Onkologie und Intensivmedizin mit den Schwerpunkten Hämatologie & internistische Onkologie, Intensivmedizin. Er ist einer der am besten bewerteten Brustkrebs- und Sarkom-Onkologen und verfügt über umfangreiche Erfahrung auf diesem Gebiet und hat Abschlüsse der Medizinischen Universität Wien und des Weizmann Institute of Science. Er hat auch eine spezielle Ausbildung am Memorial Sloan-Kettering Cancer Center und am Royal Prince Alfred Hospital absolviert.